

Compact for Safe Cosmetics
|
Animal Testing Policy |


Buy on Amazon, Support EWG!
| HIGH | UVB sunburn protection |
| MEDIUM | UVA protection |
| MEDIUM | sunscreen stability |
*Note that the same active ingredient combination may score differently in two different products depending on the concentration of the ingredients and the mixture of inactive ingredients.
Active ingredient UV |
![]() | ||||||||||||||||||||||||||||||||||||
Product total |
| ||||||||||||||||||||||||||||||||||||
| AVOBENZONE (PARSOL 1789 | BUTYL METHOXYDIBENZOYLMETHANE) (2%)  |
| ||||||||||||||||||||||||||||||||||||
| HOMOSALATE (15%)  |
| ||||||||||||||||||||||||||||||||||||
| OCTINOXATE (OCTYL METHOXYCINNAMATE) (7.5%)  |
| ||||||||||||||||||||||||||||||||||||
| OCTISALATE (5%)  |
| ||||||||||||||||||||||||||||||||||||
Given the incomplete information made available by companies and the government, EWG provides additional information on personal care product ingredients from the published scientific literature. The chart below indicates that research studies have found that exposure to one or more ingredients in this product -- not the product itself -- caused the indicated health effect(s) in the studies reviewed by Skin Deep researchers. Actual health risks, if any, will vary based on the level of exposure to the ingredient and individual susceptibility -- information not available in Skin Deep.
Ingredients in this product are linked to: | |
![]() | Cancer |
![]() | Developmental/reproductive toxicity |
![]() | Violations, restrictions & warnings |
![]() | Allergies/immunotoxicity |
![]() | Other concerns for ingredients used in this product: Neurotoxicity, Endocrine disruption, Persistence and bioaccumulation, Organ system toxicity (non-reproductive), Miscellaneous, Irritation (skin, eyes, or lungs), Enhanced skin absorption, Contamination concerns, Occupational hazards, Biochemical or cellular level changes |
Note from EWG: Unlike many other kinds of personal care products, sunscreen can provide health benefits, protecting against the sun's cancer-causing UV radiation. More than one million cases of skin cancer are diagnosed in the U.S. every year. Health officials recommend wearing sunscreen as one of many important steps to minimize skin cancer risk. (more sun safety tips)
Ingredients from packaging: Active Ingredients: Avobenzone (2%), Homosalate (15%), Octinoxate (7. 5%), Octisalate (5%). Inactive Ingredients: Paraffin, C12-15 Alkyl Benzoate, Ozokerite, Candelilla Wax, Cyclopentasiloxane, Butyloctyl Salicylate, Dibutyl Adipate, Beeswax, Neopentyl Glycol Dioctanoate, Polyethylene, Polysilicone-11, Cetyl Alcohol, Dimethicone, Tocopheryl Acetate, Ascorbyl Palmitate, Retinyl Palmitate, Neopentyl Glycol Diisosteare, BHT, Propylparaben, Fragrance.
Directions from packaging: Apply liberally 15-30 minutes before sun exposure. Reapply after swimming, towel drying, or extended sun exposure.
Warnings from packaging: For external use only. Not to be swallowed. Avoid contact with the eyes. Discontinue use if signs of irritation or rash appear. Use on children under 6 months of age only with the advice of a physician. Keep this and all drugs out of the reach of children. In case of accidental ingestion, seek professional assistance or contact a Poison Control Center right away.
| score | data gap | concerns | |
| BHT | 7 | 61% | Neurotoxicity, Endocrine disruption, Allergies/immunotoxicity, Organ system toxicity (non-reproductive), Irritation (skin, eyes, or lungs), Occupational hazards, Biochemical or cellular level changes |
| FRAGRANCE | 8 | 100% | Neurotoxicity, Allergies/immunotoxicity, Miscellaneous |
| POLYETHYLENE | 6 | 70% | Allergies/immunotoxicity, Organ system toxicity (non-reproductive), Irritation (skin, eyes, or lungs), Contamination concerns (ETHYLENE OXIDE, 1,4-DIOXANE) |
| OCTINOXATE (OCTYL METHOXYCINNAMATE) OCTINOXATE (7 5%) (Active Ingredient) | 4 | 66% | Allergies/immunotoxicity, Persistence and bioaccumulation, Enhanced skin absorption, Biochemical or cellular level changes |
| HOMOSALATE (Active Ingredient) | 4 | 74% | Violations, restrictions & warnings, Enhanced skin absorption, Contamination concerns (SALICYLIC ACID, TRIMETHYLCYCLOHEXANOL) |
| RETINYL PALMITATE | 5 | 70% | Cancer, Developmental/reproductive toxicity, Violations, restrictions & warnings, Organ system toxicity (non-reproductive), Biochemical or cellular level changes |
| PROPYLPARABEN | 4 | 82% | Developmental/reproductive toxicity, Endocrine disruption, Allergies/immunotoxicity, Organ system toxicity (non-reproductive) |
| TOCOPHERYL ACETATE | 4 | 81% | Allergies/immunotoxicity, Contamination concerns (HYDROQUINONE) |
| PARAFFIN | 1 | 79% | Occupational hazards |
| OCTISALATE (Active Ingredient) | 3 | 68% | Violations, restrictions & warnings, Allergies/immunotoxicity, Irritation (skin, eyes, or lungs), Enhanced skin absorption |
| CYCLOPENTASILOXANE | 2 | 79% | Persistence and bioaccumulation |
| DIMETHICONE | 2 | 74% | Violations, restrictions & warnings |
| AVOBENZONE (PARSOL 1789 | BUTYL METHOXYDIBENZOYLMETHANE) (Active Ingredient) | 2 | 73% | Violations, restrictions & warnings, Contamination concerns (BENZOIC ACID, 4-T-BUTYLBENZOIC ACID, BENZALDEHYDE, P-ANISIC ACID, ACETOPHENONE, DIBENZOYLMETHANE) |
| C12-15 ALKYL BENZOATE | 0 | 94% | none identified |
| OZOKERITE | 1 | 91% | none identified |
| ASCORBYL PALMITATE (VITAMIN C PALMITATE) | 1 | 88% | none identified |
| CETYL ALCOHOL | 1 | 87% | Irritation (skin, eyes, or lungs) |
| DIBUTYL ADIPATE | 1 | 83% | none identified |
| BUTYLOCTYL SALICYLATE | 1 | 76% | none identified |
| NEOPENTYL GLYCOL DIETHYLHEXANOATE NEOPENTYL GLYCOL DIOCTANOATE | 0 | 100% | none identified |
| NEOPENTYL GLYCOL DIISOSTEARATE NEOPENTYL GLYCOL DIISOSTEARE | 0 | 100% | none identified |
| POLYSILICONE-11 | 0 | 100% | none identified |
| BEESWAX | 0 | 93% | none identified |
| EUPHORBIA CERIFERA (CANDELILLA) WAX | 0 | 93% | none identified |
*This table includes all possible cancer concerns for the ingredients used by this manufacturer. Some categorizations depend on how the product is used or formulated.
| type of concern | product conditions | ingredient(s) |
| One or more animal studies show tumor formation at moderate doses | CYCLOPENTASILOXANE | |
| One or more animal studies show tumor formation at moderate doses | PARAFFIN | |
| One or more in vitro tests on mammalian cells show positive mutation results | DIBUTYL ADIPATE, TOCOPHERYL ACETATE, PROPYLPARABEN, | |
| One or more in vitro tests on mammalian cells show positive mutation results | AVOBENZONE (PARSOL 1789 | BUTYL METHOXYDIBENZOYLMETHANE) | |
| Cancer - limited evidence | RETINYL PALMITATE | |
| Cancer - not classifiable/not likely to be human carcinogen | POLYETHYLENE, BHT |
*This table includes all possible developmental/reproductive toxicity concerns for the ingredients used by this manufacturer. Some categorizations depend on how the product is used or formulated.
| type of concern | product conditions | ingredient(s) |
| One or more animal studies show reproductive effects at high doses | DIBUTYL ADIPATE | |
| One or more animal studies show reproductive effects at moderate doses | OCTINOXATE (OCTYL METHOXYCINNAMATE) | |
| One or more animal studies show reproductive effects at high doses | BHT | |
| One or more animal studies show reproductive effects at low doses | RETINYL PALMITATE, | |
| One or more animal studies show any effects at low doses | PROPYLPARABEN |
*This table includes all possible violations, restrictions & warnings concerns for the ingredients used by this manufacturer. Some categorizations depend on how the product is used or formulated.
| type of concern | product conditions | ingredient(s) |
| Determined safe for use in cosmetics, subject to concentration or use limitations - Safe for use in cosmetics with some qualifications | POLYETHYLENE, BUTYLOCTYL SALICYLATE | |
| Recommended restricted in cosmetics - use, concentration, or manufacturing restrictions - Product type restrictions or differences noted in safety assessment by industry panel | DIMETHICONE | |
| Restricted in cosmetics (recommendations or requirements) - use, concentration, or manufacturing restrictions - Use is restricted in Canadian cosmetics | RETINYL PALMITATE, OCTISALATE, HOMOSALATE, AVOBENZONE (PARSOL 1789 | BUTYL METHOXYDIBENZOYLMETHANE) |
*This table includes all possible neurotoxicity concerns for the ingredients used by this manufacturer. Some categorizations depend on how the product is used or formulated.
| type of concern | product conditions | ingredient(s) |
| One or more animal studies show brain and nervous system effects at high doses | RETINYL PALMITATE, POLYETHYLENE | |
| One or more animal studies show any effects at moderate doses | CYCLOPENTASILOXANE | |
| One or more animal studies show brain and nervous system effects at low doses | BHT | |
| Moderate evidence of human neurotoxicity | FRAGRANCE |
*This table includes all possible endocrine disruption concerns for the ingredients used by this manufacturer. Some categorizations depend on how the product is used or formulated.
| type of concern | product conditions | ingredient(s) |
| One or more studies show weak endocrine disruption | OCTINOXATE (OCTYL METHOXYCINNAMATE), HOMOSALATE | |
| One or more animal studies show endocrine disruption at moderate doses | CYCLOPENTASILOXANE | |
| Limited evidence of any disruption | PROPYLPARABEN | |
| One or more studies show endocrine system disruption at low doses | BHT |
*This table includes all possible allergies/immunotoxicity concerns for the ingredients used by this manufacturer. Some categorizations depend on how the product is used or formulated.
| type of concern | product conditions | ingredient(s) |
| Associated with immunotoxicity | AVOBENZONE (PARSOL 1789 | BUTYL METHOXYDIBENZOYLMETHANE) | |
| One or more human case studies show possible photoallergic effects | OCTINOXATE (OCTYL METHOXYCINNAMATE), OCTISALATE | |
| Human immune system toxicant - moderate evidence | POLYETHYLENE | |
| Human skin toxicant - strong evidence | TOCOPHERYL ACETATE, PROPYLPARABEN | |
| Known human immune system toxicant | FRAGRANCE, BHT |
*This table includes all possible persistence and bioaccumulation concerns for the ingredients used by this manufacturer. Some categorizations depend on how the product is used or formulated.
| type of concern | product conditions | ingredient(s) |
| Ingredient is suspected or measured to accumulate in people | OCTINOXATE (OCTYL METHOXYCINNAMATE) | |
| Persistent, bioaccumulative in wildlife | CYCLOPENTASILOXANE |
*This table includes all possible organ system toxicity (non-reproductive) concerns for the ingredients used by this manufacturer. Some categorizations depend on how the product is used or formulated.
| type of concern | product conditions | ingredient(s) |
| One or more animal studies show liver effects at high doses (low dose studies may be unavailable for this ingredient) | OCTINOXATE (OCTYL METHOXYCINNAMATE) | |
| One or more animal studies show liver effects at high doses (low dose studies may be unavailable for this ingredient) | CYCLOPENTASILOXANE, CETYL ALCOHOL, DIBUTYL ADIPATE, ASCORBYL PALMITATE (VITAMIN C PALMITATE) | |
| One or more animal studies show broad systemic effects at moderate doses (low dose studies may be unavailable for this ingredient) | TOCOPHERYL ACETATE, OCTISALATE | |
| Limited evidence of skin toxicity | RETINYL PALMITATE, PROPYLPARABEN | |
| One or more animal studies show blood effects at low doses | BHT | |
| Possible human immune system toxicant | POLYETHYLENE |
*This table includes all possible miscellaneous concerns for the ingredients used by this manufacturer. Some categorizations depend on how the product is used or formulated.
| type of concern | product conditions | ingredient(s) |
| Ingredient not fully labeled - identity unknown | FRAGRANCE |
*This table includes all possible ecotoxicology concerns for the ingredients used by this manufacturer. Some categorizations depend on how the product is used or formulated.
| type of concern | product conditions | ingredient(s) |
| Wildlife and environmental toxicity | OCTINOXATE (OCTYL METHOXYCINNAMATE) | |
| Wildlife and environmental toxicity | PROPYLPARABEN |
*This table includes all possible irritation (skin, eyes, or lungs) concerns for the ingredients used by this manufacturer. Some categorizations depend on how the product is used or formulated.
| type of concern | product conditions | ingredient(s) |
| One or more animal studies show skin irritation at moderate doses | PARAFFIN, OZOKERITE, CYCLOPENTASILOXANE | |
| One or more animal studies show skin irritation at low doses | OCTISALATE, BHT | |
| One or more animal studies show skin irritation at very low doses | CETYL ALCOHOL | |
| Human any irritant - strong evidence | products for use around the eyes, on the skin, or may be aerosolized (airborne) | POLYETHYLENE |
*This table includes all possible data gaps concerns for the ingredients used by this manufacturer. Some categorizations depend on how the product is used or formulated.
| type of concern | product conditions | ingredient(s) |
| Missing safety data noted by cosmetic industry review | POLYETHYLENE | |
| Considered safe based on assumption of low absorption | POLYETHYLENE | |
| Risk assessment method deficiencies and data gaps - Maximum reported "as used" concentration is basis of safety assessment by industry safety panel (Cosmetic Ingredient Review, CIR) - implicit safe concentration limit in product | DIBUTYL ADIPATE, TOCOPHERYL ACETATE, RETINYL PALMITATE, PROPYLPARABEN, POLYETHYLENE, PARAFFIN, OZOKERITE, DIMETHICONE, CETYL ALCOHOL, EUPHORBIA CERIFERA (CANDELILLA) WAX, BHT, BEESWAX, ASCORBYL PALMITATE (VITAMIN C PALMITATE) | |
| Not assessed for safety in cosmetics by industry panel | POLYSILICONE-11, OCTISALATE, NEOPENTYL GLYCOL DIISOSTEARATE, NEOPENTYL GLYCOL DIETHYLHEXANOATE, HOMOSALATE, FRAGRANCE, CYCLOPENTASILOXANE, C12-15 ALKYL BENZOATE, AVOBENZONE (PARSOL 1789 | BUTYL METHOXYDIBENZOYLMETHANE) |
*This table includes all possible occupational hazards concerns for the ingredients used by this manufacturer. Some categorizations depend on how the product is used or formulated.
| type of concern | product conditions | ingredient(s) |
| Allowed workplace exposures restricted to low doses | PARAFFIN, BHT |
*This table includes all possible biochemical or cellular level changes concerns for the ingredients used by this manufacturer. Some categorizations depend on how the product is used or formulated.
| type of concern | product conditions | ingredient(s) |
| Produces excess reactive oxygen species that can interfere with cellular signaling, cause mutations, lead to cell death and may be implicated in cardiovascular disease. | RETINYL PALMITATE, OCTINOXATE (OCTYL METHOXYCINNAMATE) | |
| Does not produces excess reactive oxygen species or other harmful biochemical changes. | OCTISALATE | |
| One or more animal studies show biochemical changes at low doses where the human health implications are not yet well understood | BHT | |
| One or more animal studies show biochemical changes at high doses where the human health implications are not yet well understood | CYCLOPENTASILOXANE, POLYETHYLENE |
No items in basket.
Add this product
Looking for a product report that we don't have in Skin Deep? Sign up to enter it into the Skin Deep database and leave product reviews.
We always want Skin Deep to be free to the public, but delivering high-quality research costs time and money. Help by donating just the cost of a bar of soap or bottle of shampoo.
Stay informed with email updates on toxics in everyday products and how they can affect your health.
'I just wanted to let you know how much Skin Deep has changed my daughter's (and my) life.'
—Melissa M., Michigan